Stocktoria
Corbus Pharmaceuticals Holdings, Inc. CRBP
Corbus Pharmaceuticals Holdings, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0 | $881,705 | $3.9M | $36.1M | $4.8M | $2.4M | $1.9M |
| R&D expense | $70.1M | $32.2M | $31.2M | $16.1M | $36.4M | $98.3M | $89.6M | $48.6M | $26.0M | $15.4M |
| Operating income | -$85.3M | -$48.7M | -$45.1M | -$39.8M | -$56.0M | -$122.8M | -$77.1M | -$56.7M | -$32.6M | -$20.0M |
| Income tax | $0 | $0 | — | — | — | — | — | — | — | — |
| Net income | -$78.5M | -$40.2M | -$44.6M | -$42.3M | -$45.6M | -$111.3M | -$71.5M | -$55.7M | -$32.4M | -$20.0M |
| EPS (diluted) | $-5.90 | $-3.68 | $-10.31 | $-10.15 | $-11.15 | — | — | — | — | — |
| Operating cash flow | -$64.5M | -$41.8M | -$36.1M | -$37.5M | -$48.2M | -$99.7M | -$45.7M | -$30.1M | -$27.8M | -$13.6M |
| Free cash flow | -$64.5M | -$41.8M | -$36.1M | -$37.6M | -$48.2M | -$100.2M | -$48.5M | -$32.4M | -$28.5M | -$13.9M |
| Cash & equivalents | $28.5M | $17.2M | $13.7M | $17.0M | $25.0M | $85.4M | $31.7M | $41.7M | $62.5M | $15.0M |
| Total assets | $168.2M | $155.9M | $28.3M | $66.3M | $107.7M | $102.3M | $49.1M | $47.0M | $67.0M | $17.9M |
| Total liabilities | $20.7M | $13.5M | $35.2M | $33.3M | $38.6M | $57.0M | $43.0M | $19.5M | $9.2M | $9.0M |
| Shareholders' equity | $147.5M | $142.4M | -$6.9M | $33.0M | $69.1M | $45.3M | $6.2M | $27.5M | $57.8M | $8.9M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | — | — | -100.0% | -77.6% | -89.1% | +649.5% | +97.6% | +27.7% | +194.8% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.